Table 2 Characteristics of included publications
From: Reproducible and transparent research practices in published neurology research
Characteristics | Variables | ||
|---|---|---|---|
N (%) | 95% CI | ||
Funding, N = 389 | University | 12 (3.1) | 1.4–4.8 |
Hospital | 2 (0.5) | 0–1.2 | |
Public | 79 (20.3) | 16.4–24.3 | |
Private/industry | 17 (4.4) | 2.4–6.4 | |
Non-profit | 15 (3.9) | 2.0–5.7 | |
Mixed | 100 (25.7) | 21.4–30.0 | |
No statement listed | 125 (32.1) | 27.6–36.7 | |
No funding received | 39 (10.0) | 7.1–13.0 | |
Type of study, N = 389 | No empirical data | 98 (25.2) | 20.9–29.4 |
Meta-analysis | 15 (3.9) | 2.0–5.7 | |
Commentary with analysis | 1 (0.3) | 0–0.8 | |
Cost-effectiveness | 2 (0.5) | 0–1.2 | |
Clinical trial | 29 (7.5) | 4.9–10.0 | |
Case study | 13 (3.3) | 1.6–5.1 | |
Case series | 7 (1.8) | 0.5–3.1 | |
Cohort | 54 (13.9) | 10.5–17.3 | |
Chart review | 7 (1.8) | 0.5–3.1 | |
Case control | 19 (4.9) | 2.8–7.0 | |
Survey | 5 (1.3) | 0.2–2.4 | |
Cross-sectional | 43 (11.1) | 8.0–14.1 | |
Secondary analysis | 3 (0.8) | 0–1.6 | |
Laboratory | 92 (23.7) | 19.5–17.8 | |
Multiple study types | 1 (0.3) | 0–0.8 | |
5-year impact factor, N = 372 | Median | 3.5 | – |
1st quartile | 2.6 | – | |
3rd quartile | 4.9 | – | |
Interquartile range | 2.6–4.9 | – | |